APO RESEARCH · REPORT
6-FDA
4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.
Product & engineering
Understand the product.
4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.
Selected research
Industry Research
6-FDA Industry Research Report 2026
Market perspective
4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.
Currently, Daikin, Chemours, Chinatech Chemical and Zigong Zhongtiansheng New Material are major manufacturers of this industry. Daikin is a global leader. In 2019, the company held a share of about 63%.
Japan is the largest consumption area of 6-FDA, which accounted for over 44% market share in 2019. Following Japan, Korea and USA took up market share of about 21% and 18%, which is in the second and third places.
Read the full market overview
Report Scope
This report quantifies the global 6-FDA market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 6-FDA.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
6-FDA Market by Company
Daikin
Chemours
Chinatech Chemical
Zigong Zhongtiansheng New Material
Zhejiang Nuocheng
6-FDA Segment by Purity
99% Purity 6-FDA
99.5% Purity 6-FDA
6-FDA Segment by Application
Polyimide Film
Fluorinated Polyimide
6-FDA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 6-FDA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 6-FDA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 6-FDA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 6-FDA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 6-FDA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 6-FDA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 99% Purity 6-FDA
- 99.5% Purity 6-FDA
Applications
- Polyimide Film
- Fluorinated Polyimide
Companies covered
- Daikin
- Chemours
- Chinatech Chemical
- Zigong Zhongtiansheng New Material
- Zhejiang Nuocheng
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 6-FDA by Purity
- 2.2.1 Market Value Comparison by Purity (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 99% Purity 6-FDA
- 2.2.3 99.5% Purity 6-FDA
- 2.3 6-FDA by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyimide Film
- 2.3.3 Fluorinated Polyimide
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 6-FDA Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 6-FDA Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 6-FDA Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 6-FDA Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 6-FDA Production by Manufacturers (2021-2026)
- 3.2 Global 6-FDA Production Value by Manufacturers (2021-2026)
- 3.3 Global 6-FDA Average Price by Manufacturers (2021-2026)
- 3.4 Global 6-FDA Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 6-FDA Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 6-FDA Manufacturers, Product Type & Application
- 3.7 Global 6-FDA Manufacturers Established Date
- 3.8 Global 6-FDA Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Daikin
- 4.1.1 Daikin 6-FDA Company Information
- 4.1.2 Daikin 6-FDA Business Overview
- 4.1.3 Daikin 6-FDA Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Daikin Product Portfolio
- 4.1.5 Daikin Recent Developments
- 4.2 Chemours
- 4.2.1 Chemours 6-FDA Company Information
- 4.2.2 Chemours 6-FDA Business Overview
- 4.2.3 Chemours 6-FDA Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Chemours Product Portfolio
- 4.2.5 Chemours Recent Developments
- 4.3 Chinatech Chemical
- 4.3.1 Chinatech Chemical 6-FDA Company Information
- 4.3.2 Chinatech Chemical 6-FDA Business Overview
- 4.3.3 Chinatech Chemical 6-FDA Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Chinatech Chemical Product Portfolio
- 4.3.5 Chinatech Chemical Recent Developments
- 4.4 Zigong Zhongtiansheng New Material
- 4.4.1 Zigong Zhongtiansheng New Material 6-FDA Company Information
- 4.4.2 Zigong Zhongtiansheng New Material 6-FDA Business Overview
- 4.4.3 Zigong Zhongtiansheng New Material 6-FDA Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Zigong Zhongtiansheng New Material Product Portfolio
- 4.4.5 Zigong Zhongtiansheng New Material Recent Developments
- 4.5 Zhejiang Nuocheng
- 4.5.1 Zhejiang Nuocheng 6-FDA Company Information
- 4.5.2 Zhejiang Nuocheng 6-FDA Business Overview
- 4.5.3 Zhejiang Nuocheng 6-FDA Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Nuocheng Product Portfolio
- 4.5.5 Zhejiang Nuocheng Recent Developments
5 Global 6-FDA Production by Region
- 5.1 Global 6-FDA Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 6-FDA Production by Region: 2021-2032
- 5.2.1 Global 6-FDA Production by Region: 2021-2026
- 5.2.2 Global 6-FDA Production Forecast by Region (2027-2032)
- 5.3 Global 6-FDA Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 6-FDA Production Value by Region: 2021-2032
- 5.4.1 Global 6-FDA Production Value by Region: 2021-2026
- 5.4.2 Global 6-FDA Production Value Forecast by Region (2027-2032)
- 5.5 Global 6-FDA Market Price Analysis by Region (2021-2026)
- 5.6 Global 6-FDA Production and Value, YOY Growth
- 5.6.1 North America 6-FDA Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 6-FDA Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 6-FDA Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 6-FDA Production Value Estimates and Forecasts (2021-2032)
6 Global 6-FDA Consumption by Region
- 6.1 Global 6-FDA Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 6-FDA Consumption by Region (2021-2032)
- 6.2.1 Global 6-FDA Consumption by Region: 2021-2026
- 6.2.2 Global 6-FDA Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 6-FDA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 6-FDA Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 6-FDA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 6-FDA Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 6-FDA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 6-FDA Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 6-FDA Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 6-FDA Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Purity
- 7.1 Global 6-FDA Production by Purity (2021-2032)
- 7.1.1 Global 6-FDA Production by Purity (2021-2032) & (MT)
- 7.1.2 Global 6-FDA Production Market Share by Purity (2021-2032)
- 7.2 Global 6-FDA Production Value by Purity (2021-2032)
- 7.2.1 Global 6-FDA Production Value by Purity (2021-2032) & (US$ Million)
- 7.2.2 Global 6-FDA Production Value Market Share by Purity (2021-2032)
- 7.3 Global 6-FDA Price by Purity (2021-2032)
8 Segment by Application
- 8.1 Global 6-FDA Production by Application (2021-2032)
- 8.1.1 Global 6-FDA Production by Application (2021-2032) & (MT)
- 8.1.2 Global 6-FDA Production Market Share by Application (2021-2032)
- 8.2 Global 6-FDA Production Value by Application (2021-2032)
- 8.2.1 Global 6-FDA Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 6-FDA Production Value Market Share by Application (2021-2032)
- 8.3 Global 6-FDA Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 6-FDA Value Chain Analysis
- 9.1.1 6-FDA Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 6-FDA Production Mode & Process
- 9.2 6-FDA Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 6-FDA Distributors
- 9.2.3 6-FDA Customers
10 Global 6-FDA Analyzing Market Dynamics
- 10.1 6-FDA Industry Trends
- 10.2 6-FDA Industry Drivers
- 10.3 6-FDA Industry Opportunities and Challenges
- 10.4 6-FDA Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst